Free Trial

LSV Asset Management Sells 326,160 Shares of MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

LSV Asset Management lowered its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 14.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,867,160 shares of the financial services provider's stock after selling 326,160 shares during the quarter. LSV Asset Management owned about 0.27% of MetLife worth $152,883,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Sierra Ocean LLC bought a new position in shares of MetLife during the fourth quarter valued at approximately $32,000. Retirement Wealth Solutions LLC acquired a new position in shares of MetLife during the 4th quarter valued at $32,000. Graney & King LLC bought a new stake in shares of MetLife in the 4th quarter worth approximately $34,000. Values First Advisors Inc. purchased a new stake in shares of MetLife during the fourth quarter valued at $36,000. Finally, Bank Julius Baer & Co. Ltd Zurich acquired a new position in MetLife in the 4th quarter worth approximately $48,000. 94.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on MET shares. BMO Capital Markets began coverage on MetLife in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 target price on the stock. JPMorgan Chase & Co. cut their target price on MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a research note on Wednesday, April 2nd. UBS Group lifted their price objective on MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods dropped their target price on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Finally, StockNews.com lowered MetLife from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $92.46.

View Our Latest Analysis on MET

MetLife Trading Up 0.0 %

Shares of MetLife stock traded up $0.01 during trading hours on Tuesday, hitting $72.96. The company's stock had a trading volume of 755,944 shares, compared to its average volume of 3,391,724. The company has a market capitalization of $49.70 billion, a PE ratio of 12.22, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a 50 day moving average of $80.08 and a 200 day moving average of $82.40.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines